Josh Maher
All posts from Josh Maher
Josh Maher in Josh's value investing,

Amgen's well defined path

As we outlined earlier this week to WaveBOOM members, Amgen makes up 2.2% of the Nasdaq 100 and has a very readable monthly chart. Included here, the AMGN monthly is about one of the best detailed Elliott counts you can find.  If the final subwaves are in place, the road to 60 is well defined by the blue path. Note the thick red lines showing higher highs in price vs. diverging lower highs in stochastics; a sign of weakness to come.